Beijing Tong Ren Tang Chinese Medicine Company Limited
BJTRF
$0.5645
-$0.7413-56.77%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 6.08% | -12.99% | -28.05% | -20.35% | -11.88% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 6.08% | -12.99% | -28.05% | -20.35% | -11.88% |
Cost of Revenue | 14.83% | -20.26% | -44.35% | -32.21% | -17.77% |
Gross Profit | 2.09% | -9.24% | -18.82% | -13.99% | -8.91% |
SG&A Expenses | 14.88% | 15.82% | 17.01% | 20.38% | 23.99% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | 67.17% | -17.29% | -376.23% | -290.78% | -224.38% |
Total Operating Expenses | 15.60% | -5.56% | -23.18% | -13.68% | -2.73% |
Operating Income | -7.66% | -22.99% | -34.25% | -28.45% | -22.42% |
Income Before Tax | -8.11% | -20.85% | -30.59% | -23.88% | -16.70% |
Income Tax Expenses | 3.90% | -22.00% | -39.81% | -33.91% | -27.81% |
Earnings from Continuing Operations | -10.08% | -20.65% | -28.87% | -21.97% | -14.54% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 42.29% | 34.62% | 27.44% | 10.01% | -10.50% |
Net Income | -7.09% | -19.47% | -28.98% | -22.85% | -16.30% |
EBIT | -7.66% | -22.99% | -34.25% | -28.45% | -22.42% |
EBITDA | -7.11% | -22.24% | -33.45% | -27.71% | -21.75% |
EPS Basic | -7.03% | -19.39% | -28.97% | -22.78% | -16.16% |
Normalized Basic EPS | -3.63% | -18.83% | -30.26% | -24.63% | -18.71% |
EPS Diluted | -7.03% | -19.39% | -28.97% | -22.78% | -16.16% |
Normalized Diluted EPS | -3.63% | -18.83% | -30.26% | -24.63% | -18.71% |
Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | 0.08% | 0.24% | 0.41% | 0.40% | 0.41% |